Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of PEG-interferon alfa-2a in hepatitis B virus carriers with low HBV-DNA load
ChiCTR-OPC-14005267Phase 4Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Sep 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of interferon alfa in hepatitis B (HBV) (3 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoints: HBV-DNA, HBsAg and 1 more. Started Sep 2014; status: recruiting.
02
Drugs
interferon alfa
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR-OPC-14005267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-14005267.